Journal article
c-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks.
- Abstract:
-
Prostate cancer (PCa) is the most common non-cutaneous cancer in men. The androgen receptor (AR), a ligand-activated transcription factor, constitutes the main drug target for advanced cases of the disease. However, a variety of other transcription factors and signaling networks have been shown to be altered in patients and to influence AR activity. Amongst these, the oncogenic transcription factor c-Myc has been studied extensively in multiple malignancies and elevated protein levels of c-My...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Norwegian Cancer Society
More from this funder
South-East Norway Health Authorities
More from this funder
Norwegian Centre for Molecular Medicine
More from this funder
Norwegian Research Council
More from this funder
Norwegian Cancer Society
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- EBioMedicine Journal website
- Volume:
- 18
- Pages:
- 83-93
- Publication date:
- 2017-04-01
- Acceptance date:
- 2017-04-04
- DOI:
- EISSN:
-
2352-3964
- Pmid:
-
28412251
- Source identifiers:
-
817470
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:817470
- UUID:
-
uuid:9e3b262c-6991-4e69-b56d-4e146e163d06
- Local pid:
- pubs:817470
- Deposit date:
- 2018-01-11
Terms of use
- Copyright holder:
- Crown Copyright
- Copyright date:
- 2017
- Notes:
- Crown Copyright © 2017 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record